Surgery Partners (SGRY) Cash & Current Investments (2014 - 2026)

Surgery Partners has reported Cash & Current Investments for 13 years, with the latest figure at $182.3 million in Q1 2026.

• Quarterly Cash & Current Investments fell 20.5% year-over-year to $182.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $182.3 million (down 20.5% YoY) and the FY2025 annual result came in at $239.9 million, down 10.98% from the prior year.
• Cash & Current Investments declined to $182.3 million in Q1 2026 per SGRY's latest filing, from $239.9 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $378.9 million in Q1 2022 and troughed at $154.8 million in Q3 2022.
• A 5-year average of $229.0 million and a median of $227.4 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments slumped 53.15% in 2022, then surged 52.45% in 2023.
• Over 5 years, Cash & Current Investments stood at $282.9 million in 2022, then slumped by 30.75% to $195.9 million in 2023, then soared by 37.57% to $269.5 million in 2024, then fell by 10.98% to $239.9 million in 2025, then declined by 24.01% to $182.3 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $182.3 million, $239.9 million, and $203.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.